Autonomous Therapeutics
Autonomous Therapeutics was founded in 2017 by a team from Harvard Medical School and UCSF. We're developing new classes of target-activated (and resistance-proof) medicines from influenza to colon cancer. Our technology is built around a simple idea: precision nucleic acids that sense and only activate in diseased cells, avoiding healthy cells. Reach out with a CV if you're interested in learning more and joining us!
7-day free trial · no credit card
Verified contacts
17
available on Kipplo
LinkedIn employees
21
11 to 50 range
Open roles
—
no listings
Distinct roles
10
indexed titles
Tech stack
1
tools in use
Monthly traffic
1.5K
organic / mo
Sign up free to see all 17 verified contacts at Autonomous Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
17 contacts with verified email or phone · masked until revealed.
- AS
Anton Shemetov
Principal Scientist · Science
EmailPhone - KV
Kartik Venkat
Robotics Engineer · Engineering
EmailPhone - JB
Joseph Bauman
, - · Other
EmailPhone - SW
Susan Weinberger
VP of Administration · General Business & Management
EmailPhone - AW
Ariel Weinberger
CEO & Founder · Other
EmailPhone - TM
Taylor Moon
Senior Scientist, in Vivo Biologist · Other
EmailPhone
Showing 6 of 17 verified contacts
Top roles at Autonomous Therapeutics
10 distinct titles indexed · top 10 shown.
- 7senior scientist
- 1, -
- 1associate director rna virology
- 1associate scientist ii
- 1ceo & founder
- 1lab manager
- 1principal scientist
- 1robotics engineer
- 1senior scientist, in vivo biologist
- 1vp of administration
Sign up to unlock all 17 contacts at Autonomous Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 17 verified contacts at Autonomous Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.